Jennifer E Marfori, MD | |
9155 Sw Barnes Rd Ste 638, Portland, OR 97225-6633 | |
(503) 216-7000 | |
(503) 216-6999 |
Full Name | Jennifer E Marfori |
---|---|
Gender | Female |
Speciality | Infectious Disease |
Experience | 24 Years |
Location | 9155 Sw Barnes Rd Ste 638, Portland, Oregon |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407802143 | NPI | - | NPPES |
227432 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | MD23882 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Providence St Vincent Medical Center | Portland, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Providence Health And Services Oregon | 0648183608 | 1328 |
News Archive
Researchers at the Norris Cotton Cancer Center and University of Hawaii Cancer Center find that one-third of Hawaiian adolescents have tried e-cigarettes, half of whom have never used another tobacco product.
USAID's "IMPACTblog" features a "video of the week" from the State Department's Feed the Future initiative. In the three-minute video, "narrator Matt Damon discusses U.S. efforts to turn the tide against global hunger and increase agricultural production around the world through Feed the Future," according to the blog.
In Alaska, Gov. Sean Parnell said Friday his state will not expand Medicaid under the health law, while reports from Wisconsin, Pennsylvania, North Carolina and Maine assess the decisions - and, in some cases, continued lobbying - in those states.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today offered additional commentary, clarifications and insights on yesterday's announcement of its Phase IIa clinical results of Serdaxin® in the treatment of major depressive disorder (MDD).
Atrium Medical Corporation is pleased to announce that the final patient was recently enrolled in the iCAST™ Atrium Registry Ultrasound Study (iCARUS). This study is a prospective, multi-center clinical trial studying the safety and efficacy of the Atrium iCAST™ Balloon Expandable Covered Stent in patients with occlusive disease of the iliac artery.
› Verified 9 days ago
Entity Name | Providence Health & Services Oregon |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023488343 PECOS PAC ID: 0648183608 Enrollment ID: O20031106000652 |
News Archive
Researchers at the Norris Cotton Cancer Center and University of Hawaii Cancer Center find that one-third of Hawaiian adolescents have tried e-cigarettes, half of whom have never used another tobacco product.
USAID's "IMPACTblog" features a "video of the week" from the State Department's Feed the Future initiative. In the three-minute video, "narrator Matt Damon discusses U.S. efforts to turn the tide against global hunger and increase agricultural production around the world through Feed the Future," according to the blog.
In Alaska, Gov. Sean Parnell said Friday his state will not expand Medicaid under the health law, while reports from Wisconsin, Pennsylvania, North Carolina and Maine assess the decisions - and, in some cases, continued lobbying - in those states.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today offered additional commentary, clarifications and insights on yesterday's announcement of its Phase IIa clinical results of Serdaxin® in the treatment of major depressive disorder (MDD).
Atrium Medical Corporation is pleased to announce that the final patient was recently enrolled in the iCAST™ Atrium Registry Ultrasound Study (iCARUS). This study is a prospective, multi-center clinical trial studying the safety and efficacy of the Atrium iCAST™ Balloon Expandable Covered Stent in patients with occlusive disease of the iliac artery.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Jennifer E Marfori, MD Po Box 3158, Portland, OR 97208-3158 Ph: (503) 215-6494 | Jennifer E Marfori, MD 9155 Sw Barnes Rd Ste 638, Portland, OR 97225-6633 Ph: (503) 216-7000 |
News Archive
Researchers at the Norris Cotton Cancer Center and University of Hawaii Cancer Center find that one-third of Hawaiian adolescents have tried e-cigarettes, half of whom have never used another tobacco product.
USAID's "IMPACTblog" features a "video of the week" from the State Department's Feed the Future initiative. In the three-minute video, "narrator Matt Damon discusses U.S. efforts to turn the tide against global hunger and increase agricultural production around the world through Feed the Future," according to the blog.
In Alaska, Gov. Sean Parnell said Friday his state will not expand Medicaid under the health law, while reports from Wisconsin, Pennsylvania, North Carolina and Maine assess the decisions - and, in some cases, continued lobbying - in those states.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today offered additional commentary, clarifications and insights on yesterday's announcement of its Phase IIa clinical results of Serdaxin® in the treatment of major depressive disorder (MDD).
Atrium Medical Corporation is pleased to announce that the final patient was recently enrolled in the iCAST™ Atrium Registry Ultrasound Study (iCARUS). This study is a prospective, multi-center clinical trial studying the safety and efficacy of the Atrium iCAST™ Balloon Expandable Covered Stent in patients with occlusive disease of the iliac artery.
› Verified 9 days ago
Salona Shrestha, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |